TL;DR
Significant reductions in new childhood HIV infections have been achieved through testing and treatment, bringing an HIV-free generation closer. However, funding cuts and access barriers threaten to undo these progress milestones.
Recent data indicates that new HIV infections among children have fallen significantly, with some countries approaching near-elimination levels, but persistent funding cuts and access issues threaten to reverse these gains.
Over the past three decades, countries like Uganda and Botswana have implemented effective strategies—such as routine HIV testing for expectant parents and widespread use of antiretroviral therapy (ART)—to drastically reduce mother-to-child transmission of HIV. In Uganda, the rate of new childhood infections has dropped from 32,000 annually in the 1990s to fewer than 5,000 today, representing a major public health achievement.
Despite these successes, approximately 120,000 children are still newly infected with HIV each year globally, mostly during pregnancy, childbirth, or breastfeeding. Many of these children do not receive timely diagnosis or treatment, leading to approximately 75,000 deaths annually. The barriers include limited access to testing, treatment, and ongoing care, especially in high-burden regions.
Recent political and financial shifts, including US foreign aid reductions, have raised concerns about the sustainability of these programs. UNAIDS projects that continued aid cuts could result in an additional 1.1 million HIV infections among children between 2024 and 2040, and 820,000 more deaths, threatening the progress made so far.
Why It Matters
This development matters because reducing childhood HIV infections is a critical step toward ending the AIDS epidemic. Achieving an HIV-free generation would save thousands of lives annually, reduce long-term healthcare costs, and demonstrate the effectiveness of targeted prevention strategies. The potential reversal of progress due to funding cuts underscores the importance of sustained international support and health system strengthening.
HIV testing kit for expectant mothers
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
In the 1990s, high HIV prevalence in Uganda and other African countries led to hundreds of thousands of children being born with HIV each year. The global health community responded with interventions like routine testing and ART, which dramatically lowered transmission rates. Countries like Botswana have now reached levels where new pediatric infections are exceedingly rare, sparking optimism about eventual elimination.
However, progress has not been uniform. Many regions still struggle with high infection rates, stigma, and limited healthcare infrastructure. Recent political shifts, including reductions in US foreign aid, threaten to undermine these advances, risking a resurgence of new infections and preventable deaths.
“We are actually confronting what it will take to finish this job. That is profound. That is progress.”
— Doris Macharia, President of the Elizabeth Glaser Pediatric AIDS Foundation
“I’ve seen an uptick in babies born with HIV again. It takes me back to those days when there was no access to medication or research.”
— Ismail Harerimana, community health worker in Uganda
antiretroviral therapy (ART) medication
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It remains unclear how sustained the recent progress will be amid ongoing funding uncertainties and health system disruptions. The exact pace at which new infections could rise if aid is further reduced is still being modeled, and the impact of emerging prevention drugs like Lenacapavir is not yet fully known.
HIV prevention educational books
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
Next steps include maintaining and increasing funding for HIV prevention programs, expanding access to testing and treatment, and implementing innovative prevention strategies. Monitoring and evaluating progress will be essential, alongside advocacy for sustained international support to prevent reversals in gains.
breastfeeding HIV prevention support
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How close are we to eliminating mother-to-child HIV transmission?
Some countries like Botswana are approaching near-elimination levels, but globally, the rate remains significant, with about 120,000 new infections annually.
What are the main barriers to ending childhood HIV?
Limited access to testing, treatment, and healthcare infrastructure, along with stigma and funding shortages, are primary obstacles.
How do funding cuts impact HIV prevention efforts?
Funding reductions threaten to reverse progress by reducing access to testing, antiretroviral therapy, and prevention programs, potentially leading to more infections and deaths.
Are new HIV prevention drugs helping in this effort?
Yes, drugs like Lenacapavir show promise, but their widespread impact depends on continued research, approval, and access, which are still developing.
What can be done to ensure continued progress?
Sustained international funding, health system strengthening, community engagement, and policy support are essential to maintain and accelerate progress toward an HIV-free generation.
